Infectious Disease
115
19
21
63
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
11 trials with published results (10%)
Research Maturity
63 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
3 terminated out of 115 trials
95.5%
+8.9% vs benchmark
7%
8 trials in Phase 3/4
17%
11 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 63 completed trials
Clinical Trials (115)
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Compliant Analysis of Patient Samples and Data
An International Observational Study of Adults With Acute Infection
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
Genetic Susceptibility to Severe Infections
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases
Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care
L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)
Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
CytOSorb TreatMent Of Critically Ill PatientS Registry
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
Vitality in Infants Via Azithromycin for Neonates Trial
Antibiotic Therapy in Viral Airway Infections